QGEN: Qiagen N.V. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 9,463.00
Enterprise Value ($M) 10,304.71
Book Value ($M) 3,807.76
Book Value / Share 17.20
Price / Book 2.49
NCAV ($M) -159.87
NCAV / Share -0.72
Price / NCAV -59.19

Profitability (mra)
Return on Invested Capital (ROIC) 0.06
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.10

Liquidity (mrq)
Quick Ratio 1.62
Current Ratio 1.99

Balance Sheet (mrq) ($M)
Current Assets 2,147.56
Assets 6,115.19
Liabilities 2,307.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,965.31
Operating Income 453.65
Net Income 341.30

Cash Flow Statement (mra) ($M)
Cash From Operations 459.45
Cash from Investing -87.66
Cash from Financing -433.83

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-09 13G/A Massachusetts Financial Services Co /ma/ 10.50 -0.26
01-23 13G/A BlackRock Inc. 12.00 -12.67

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 97,804 954,501 10.25
2024-03-27 89,574 732,909 12.22
2024-03-26 129,759 807,191 16.08
2024-03-25 81,133 913,880 8.88

(click for more detail)

Similar Companies
PBH – Prestige Consumer Healthcare Inc. PFE – Pfizer Inc.
PRGO – Perrigo Company plc RCUS – Arcus Biosciences, Inc.
TARO – Taro Pharmaceutical Industries Ltd.


Financial data and stock pages provided by
Fintel.io